DGM
ABVX

Darwin Global Management’s Abivax ABVX Stock Holding History

Darwin Global Management’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$348M Buy
3,621,583
+152,926
+4% +$17.3M 9.26% 4
2026
Q1 		$352M Buy
3,468,657
+290,156
+9% +$34.3M 9.34% 3
2025
Q4 		$440M Buy
3,178,501
+14,000
+0.4% +$1.53M 8.9% 3
2025
Q3 		$264M Buy
+3,164,501
New +$194M 7.33% 3

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Darwin Global Management's ABVX Position: Q2 2026 in Review

Darwin Global Management increased its Abivax (ABVX) stake by 4.4% in Q2 2026, buying an estimated $17.3M and bringing the position to 3,621,583 shares worth $348M. The position accounts for 9.26% of the portfolio, ranked #4.

Darwin Global Management first reported a position in ABVX in Q3 2025 and has held it in 4 quarters since. The position peaked at $440M in Q4 2025. 302 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Darwin Global Management held 3,621,583 shares of Abivax worth $348M as of Q2 2026.
  • Darwin Global Management bought 152,926 Abivax shares in Q2 2026, an estimated $17.3M.
  • Abivax made up 9.26% of Darwin Global Management's portfolio in Q2 2026, its #4 holding.
  • Darwin Global Management first reported a position in Abivax in Q3 2025 and has held it in 4 quarters since.
  • Darwin Global Management's Abivax position peaked at $440M in Q4 2025.
  • 302 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Darwin Global Management's 13F filing for Q2 2026, filed 14 Aug 2026.